Presentations we supply
- Tablet 2.5 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for LetrozoleReference information
Summarised from the product information for Femara (UK product information). Always follow the product information approved in your own country.
- Active substance
- Letrozole
- Pharmacotherapeutic group
- Endocrine therapy, hormone antagonists and related agents, aromatase inhibitors (ATC code L02BG04)
- Authorised uses
- Adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women
- Extended adjuvant treatment of hormone-dependent breast cancer after 5 years of tamoxifen
- First-line treatment of hormone-dependent advanced breast cancer in postmenopausal women
- Advanced breast cancer after relapse or progression following anti-oestrogen therapy
- Neoadjuvant treatment of hormone receptor-positive, HER2-negative breast cancer
- Storage (unopened)
- Do not store above 30 °C. Store in the original package in order to protect from moisture.
- Shelf life (unopened)
- 3 years
- Container and pack
- PVC/PE/PVDC/aluminium blisters; packs of 10, 14, 28, 30 or 100 tablets
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Femara: www.medicines.org.uk